Altimmune, Inc. Banner Image

Altimmune, Inc. has reached its limit for free report views

Work for Altimmune, Inc.? Upgrade Your Profile and unlock all your annual reports.

Altimmune, Inc.

  • Ticker ALT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Altimmune, Inc. Logo Image
  • 51-200 Employees
  • Based in Gaithersburg, Maryland
Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Their diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptideMore therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™).
Altimmune, Inc.

Most Recent Annual Report

Altimmune, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Report Locked. Altimmune, Inc. has reached its limit for free report views.

Older/Archived Annual Reports